Search for: "Wyeth Pharmaceuticals Company, Inc." Results 101 - 120 of 282
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment:… [read post]
22 Jun 2010, 6:56 am
On Scroggin's behalf, personal injury product liability attorneys sued drug makers Wyeth Pharmaceuticals and Upjohn Co., both now subsidiaries of Pfzier Inc., claiming that hormone replacement drugs they manufactured were responsible for Scroggin's breast cancer. [read post]
2 Aug 2012, 10:17 am by FDABlog HPM
May 2, 2012) denying Mutual Pharmaceutical Company’s (“Mutual’s”) appeal of a decision from the U.S. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
15 Apr 2014, 9:29 am by Ronald Mann
  To be sure, the Court has barred suits against generic manufacturers in two decisions following up on Wyeth (PLIVA, Inc. v. [read post]
29 Mar 2007, 4:46 am
Wyeth Labs., Inc., 161 N.J. 1, 25 (1999). [read post]
11 May 2012, 8:28 am by Joshua Matz
Mutual Pharmaceutical Company, involving the interpretation of two recent Supreme Court decisions – Wyeth v. [read post]